ContributorsPublishersAdvertisers

Landmark treatment: Cell therapy advances options for corneal endothelial disease

ophthalmologytimes.com
 2021-10-13

Cover picture for the articleResults from Aurion Biotech's IOTA trial reveals that a corneal endothelial cell therapy showed improvements in visual acuity and central corneal thickness, according to a team of Japanese investigators. A cell therapy developed by a team of Japanese investigators has driven Aurion Biotech’s IOTA trial, and the company recently...

www.ophthalmologytimes.com

Comments / 0

Comments / 0